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Abstract
Vaginal Escherichia coli colonization is related to obstetric infections and the consequent
development of infections in newborns. Ampicillin resistance among E. coli strains is
increasing, which is the main choice for treating empirically many obstetric and neonatal
infections. Vaginal E. coli strains are very similar to extraintestinal pathogenic E. coli with
regards to the virulence factors and the belonging to phylogroup B2. We studied the antimi-
crobial resistance and the genetic virulence profile of 82 E. coli isolates from 638 vaginal
samples and 63 isolated from endometrial aspirate, placental and amniotic fluid samples
from pregnant women with obstetric infections. The prevalence of E. coli in the vaginal sam-
ples was 13%, which was significant among women with associated risk factors during
pregnancy, especially premature preterm rupture of membranes (p<0.0001). Sixty-five per-
cent of the strains were ampicillin-resistant. The E. coli isolates causing obstetric infections
showed higher resistance levels than vaginal isolates, particularly for gentamicin (p =
0.001). The most prevalent virulence factor genes were those related to the iron uptake sys-
tems revealing clear targets for interventions. More than 50% of the isolates belonged to the
virulent B2 group possessing the highest number of virulence factor genes. The ampicillin-
resistant isolates had high number of virulence factors primarily related to pathogenicity
islands, and the remarkable gentamicin resistance in E. coli isolates from women presenting
obstetric infections, the choice of the most appropriate empiric treatment and clinical man-
agement of pregnant women and neonates should be carefully made. Taking into account
host-susceptibility, the heterogeneity of E. coli due to evolution over time and the geographi-
cal area, characterization of E. coli isolates colonizing the vagina and causing obstetric
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infections in different regions may help to develop interventions and avoid the aetiological
link between maternal carriage and obstetric and subsequent puerperal infections.
Introduction
Escherichia coli are reported as one of the most common organisms found in the genital tract
of non-pregnant (9–28%) and pregnant women (24–31%). Vaginal E. coli (VEC) strains are
considered to be a reservoir for vaginal and/or endocervical colonization in pregnant women,
and an important step in the development of urinary tract, intra-amniotic and puerperal infec-
tions through ‘fecal-vaginal-urinary/neonatal’ transmission [1,2]. Histologically, subclinically
or clinically diagnosed chorioamnionitis is an obstetric infection caused principally by ascend-
ing microorganisms from the vagina which may lead to maternal or foetal complications,
including postpartum endometritis, bacteraemia or sepsis. E. coli is considered to be normally
involved in these infections despite their polymicrobial susceptibility [3].
The most frequent antibiotic treatment for preterm rupture of membranes, suspected chor-
ioamnionitis or neonatal sepsis and bacterial meningitis is ampicillin plus an aminoglycoside,
normally gentamicin, whereas for postpartum endometritis, clindamycin or ampicillin plus
gentamicin are prescribed. Nevertheless, an increase of treatment failure has been observed
due to the high percentage of ampicillin resistance found among E. coli strains [4].
The status of the immune system and host susceptibility play an important role in the out-
come of an infection and disease progression [5]. However, extraintestinal infection is associ-
ated with a broad range of virulence factors (VFs) including adhesins, toxins, siderophores and
invasins, among others [6–8]. VEC strains share a virulence factor profile with extraintestinal
pathogenic isolates of E. coli (ExPEC), which are different from commensal flora and allow
them to colonize, avoid defense mechanisms and cause extra-intestinal infections [1], [5,6], [9].
Most ExPEC are assigned to the virulent phylogenetic group B2, followed by group D, whilst
groups A and B1 are frequently associated with commensal strains based on the old classifica-
tion created by Clermont et al. [10]. Similar results have been observed for E. coli isolates caus-
ing bacteraemia among pregnant women and urinary tract infections (UTIs) with the revised
method [11–13]
Due to the selective pressure in the habitats, commensal E. coli can turn into virulent and
resistant strains [14]. VEC isolates from pregnant women may be related to obstetric infections
and the consequent development of infections in newborns. In addition, these strains may be
resistant to empiric treatment resulting in therapeutic failure. Therefore, the aim of this study
was to characterize and compare 145 E. coli isolates from vaginal samples (colonizing) and
samples of women with obstetric infections in terms of antimicrobial resistance, phylotype and
the virulence profile in order to determine their virulence potential.
Materials and Methods
Clinical Sample Collection and Isolation of E. coli
Two types of isolates were collected from pregnant women at the Maternity Fetal Medicine
Department of the Hospital Clinic of Barcelona (Fig 1). On one hand, a total of 638 vaginal
samples were collected on one of the antenatal visits from February 2011 to June 2013. These
vaginal samples included (A) 603 from pregnant women with normal gestation and (B) 35
from pregnant women with associated risk at delivery (premature preterm rupture of mem-
branes or preterm labour). On the other hand, 63 E. coli isolates were collected from
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endometrial aspirate, amniotic fluid or placenta of pregnant women with obstetric infections,
including postpartum endometritis and clinical or subclinical intraamniotic infection from
February 2011 to December 2014. The “Comité Ético de Investigación Clínica (CEIC)” of the
Hospital Clinic of Barcelona, formed by Dr. Begoña López Pérez and Dr. Joan Albert Barberá
Mir, approved the project (Ref. 2010/5720) and all women provided informed signed consent.
All the samples were spread onto MacConkey Agar and incubated at 37°C overnight. Suspected
colonies were confirmed by MALDI-TOF.
Antimicrobial Resistance
Resistance profiles were determined using the standard Kirby-Bauer disk-diffusion method.
The antimicrobial agents tested were ampicillin (AMP), amoxicillin/clavulanic acid (AMC),
cefuroxime (CXM), cefotaxime (CTX), ceftazidime (CAZ), imipenem (IPM), tetracycline
(TET), trimethoprim/ sulfamethoxazole (SXT), amikacin (AMK), gentamicin (GEN), cipro-
floxacin (CIP), chloramphenicol (CHL), and fosfomycin (FOF). In addition, an Extended-
Spectrum Beta-Lactamase (ESBL) confirmatory test using CTX, AMC and CAZ was carried
out [15]. The results were interpreted following Clinical and Laboratory Standards Institute
guidelines [16] and the E. coli ATCC25922 strain was used as the control.
Prevalence of virulence factors genes
The virulence profile was analysed by PCR using gene-specific primers for 13 genes encoding
virulence determinants usually associated with extraintestinal E. coli strains. The genes studied
included: hemolysin (hlyA), cytotoxic necrotizing factor (cnf1), autotrasporter toxin (sat1), P-
fimbriae (papA, -EF, -C), type 1-C fimbriae (focG), heat-resistant hemagglutinin (hra), yersi-
niabactin (fyuA), siderophores (iutA and iroN), aerobactin (iucC) and invasion of brain endo-
thelium factor (ibeA) [17]. PCR was performed under the following conditions: initial
denaturation at 94°C for 3 min, followed by 25 cycles of denaturation at 94°C for 30 s, the cor-
responding annealing temperature (55–63°) for 30 s, an extension at 72°C for 1 min and 30 s,
and a final elongation at 72°C for 7 min. The amplification products were separated in 1.5%
agarose gels and stained with Syber Safe. A 100-bp DNA ladder was used in each gel as a
molecular size marker. Several strains previously characterized in terms of virulence in our lab-
oratory were used as positive controls. The results were considered to be positive if the amplifi-
cation product was similar to the expected molecular size.
Fig 1. Diagram flow of the clinical sample collection. *PROM: Premature Rupture of Membranes;
**pPROM: preterm PROM.
doi:10.1371/journal.pone.0146531.g001
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Phylogenetic analysis
The new and improved E. coli phylo-typing method with several modifications described by
Clermont at al. [13] was used to identify E. coli isolates belonging to the eight phylogroups (B2,
D, B1, A, E, Non-typeable, F, C, and E clade 1). A simplex PCR method was utilized to deter-
mine the arpA, chuA, yjaA and TspE4.C2 genes and the concentration of the primers was 5μM
instead of a quadruplex-PCR with a concentration of 20 μM.
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics software for Windows, version
20.0. Comparisons of associations between antibiotic susceptibility, the phylogenetic group
and the presence of virulence factor genes (VFGs) were made using the chi-square test when all
the expected cell frequencies were 5, the chi-square with Yates’ correction when the number
of expected cases was between 3 (inclusive) and 5 and the Fisher’s exact test when the number
of expected cases was below 3 in at least one group. A p-value below 0.05 was considered statis-
tically significant and p-values below 0.01 were highly significant.
Results
Prevalence of E.coli among the vaginal samples
Among the 638 vaginal samples collected, 82 isolates (13%) were positive for E. coli, and this
was statistically or highly significant among women belonging to group B compared to group
A (n = 13, 37% versus n = 69, 11% respectively; p = 0.0001) (Table 1). In addition, premature
preterm rupture of membranes (pPROM) was the most prevalent risk factor (n = 12, 92%)
among pregnant women with infection by E. coli.
Antimicrobial susceptibility
Sixteen obstetric infection E. coli (obstetric IEC) (25%) and 29 VEC isolates (5%) were suscepti-
ble to all the antimicrobial agents tested. Ninety-five (65.5%) of all the isolates were resistant to
ampicillin. Obstetric IEC isolates showed higher percentages of resistance to all the antibiotics
than VEC isolates except for imipenem (only one vaginal resistant isolate), which was highly
significant for gentamicin (22.2% versus 3.7%, respectively; p = 0.001) (Fig 2). The presence of
ESBLs was only found in one isolate from a pregnant woman with puerperal endometritis har-
bouring the CTX-M-15 enzyme.
Prevalence of virulence factor genes
Among all the isolates, the most prevalent VFGs were those related to the iron uptake systems:
fyuA (79.3%), iucC (55.9%) and iutA (53.8%) (Table 2). No significant differences were found
Table 1. Prevalence of Escherichia coli among vaginal samples from pregnant women with normal
gestation (A) and some risks at birth (B).
Pregnant women Presence of E. coli Absence of E. coli Total
(A) with normal gestation 69 (11) 534 (89) 603
(B) with some risks at birth 13 (37) ** 22 (63) 35
Total 82 (13) 556 (87) 638
Data are shown as no. (%).
**p-value: p = 0.000015
doi:10.1371/journal.pone.0146531.t001
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between obstetric IEC and VEC isolates apart from invasin ibeA which was more frequently
found among VEC isolates (n = 13, 15.9% versus n = 2, 3.2%, p = 0.014). The VFG less fre-
quently found in all the isolates was focG (VEC: 11%, obstetric IEC: 6%).
Phylogenetic group distribution
Seventy-six (52%) of all the isolates belonged to the B2 group and to a lesser extent to groups A
and E (15% and 12%, respectively) (Fig 3). The presence of the other phylo-groups was lower,
being 21% of the remaining phylo-groups. Significant differences were found when phylo-
group B2 was compared with all the others separately (p<0.01 in all cases), but no differences
were observed between VEC and obstetric IEC isolates.
Relationship between the phylogenetic group, virulence factors and
antimicrobial resistance
Statistically significant differences were found in the presence of VFGs among isolates belong-
ing to phylogenetic group B2, being hlyA (p<0.0001), cnf1 (p<0.0001), papA (p = 0.003),
papC (p = 0.011), focG (p = 0.002), hra (p = 0.009), fyuA (p<0.0001) and ibeA (p = 0.001) the
most representative of this group regarding all the isolates, whereas iutA and iucC were more
frequently observed among the non-B2 groups (Table 3).
Fig 2. Distribution of antimicrobial resistance among VEC and obstetric IEC isolates. VEC isolates: vaginal Escherichia coli isolates; Obstetric IEC
isolates: obstetric infection Escherichia coli isolates. AMP, ampicillin; AMC, amoxicillin/clavulanic acid; CXM, cefuroxime, CTX, cefotaxime; CAZ,
ceftazidime; IPM, imipenem; TET, tetracycline, SXT, trimethoprim/ sulfamethoxazole; AMK, amikacin; GEN, gentamicin; CHL, chloramphenicol; CIP,
ciprofloxacin and FOF, fosfomycin. (**p-value = 0.001).
doi:10.1371/journal.pone.0146531.g002
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Table 2. Prevalence of virulence factor genes (VFGs) according to the type of isolate.
Type of isolate
VFGsa VECb (n = 82) Obstetric IECc (n = 63) Total (n = 145)
hlyA 19 (23) 12 (19) 31 (21)
cnf1 18 (22) 16 (25) 34 (23)
sat1 29 (35) 27 (43) 56 (39)
papA 23 (28) 28 (44) 51 (35)
papEF 21 (26) 17 (27) 38 (26)
papC 20 (24) 24 (38) 44 (30)
focG 9 (11) 4 (6) 13 (9)
hra 29 (35) 22 (35) 51 (35)
fyuA 66 (80) 48 (76) 114 (79)
iutA 37 (45) 40 (63.5) 77 (53)
iroN 29 (35) 23 (37) 52 (36)
iucC 41 (50) 39 (62) 80 (55)
ibeA 13 (16)* 2 (3) 15 (10)
aVFGs: Virulence Factor Genes
bVEC: Vaginal Escherichia coli
cObstetric IEC: Obstetric Infection Escherichia coli
*p-value = 0.014
doi:10.1371/journal.pone.0146531.t002
Fig 3. Distribution of phylogenetic groups among the isolates.
doi:10.1371/journal.pone.0146531.g003
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Ampicillin-resistant VEC isolates showed a greater number of VFs in comparison with
ampicillin-susceptible isolates, being highly significant for the hlyA (p = 0.001), cnf1
(p = 0.001), papEF (p = 0.01), hra (p = 0.005), fyuA (p = 0.001), and iroN (p<0.001) genes.
However, VFGs tended to be more frequent among ampicillin-susceptible obstetric IEC iso-
lates. Iron acquisition systems, such as fyuA and iroN, were also significantly more prevalent
among tetracycline-resistant VEC isolates than their susceptible counterparts (fyuA: p = 0.023
and iroN: p = 0.008). However, tetracycline-resistant isolates from obstetric infection showed
fewer VFs, being significant for hlyA (p = 0.009), cnf1 (p = 0.019), papA (p = 0.005) and papC
(p = 0.014). In addition, the aerobactin synthesis gene iucC was significantly more frequently
found among the tetracycline, trimethoprim/sulfamethoxazole, gentamicin and chlorampheni-
col-resistant isolates in comparison with the susceptible isolates. No highly significant differ-
ences were found in the distribution of the phylotype and antimicrobial agents.
Discussion
The prevalence of vaginal E. coli found in this study was 13% similar to results of previous stud-
ies [17,18], but lower than in others [19]. In addition, the noteworthy percentage of maternal
E. coli carriers suggests that vaginal E. coli colonization is a risk factor for pPROM and preterm
birth [20,21] as well as the starting point for progression to severe infection [11].
A review of the current empiric treatment may be necessary, considering the high preva-
lence of ampicillin and gentamicin resistance in E. coli isolates collected from women with
postpartum endometritis and intraamniotic infection, in agreement with previous reports [18],
[22]. Therefore, the use of cephalosporines as first-line therapy for the treatment of mothers
and neonates may be effective due to the high percentages of susceptibility [7], [23] and good
outcomes shown in the treatment of peripartum sepsis [24]. Nevertheless, the geographical
area should also be taken into account because of the particular increase in infections due to
ESBL-producing organisms worldwide [18], [25], especially in developing countries [26].
The high presence of iron acquisition systems among the isolates was notable, with yersinia-
bactin (fyuA) being the most prevalent VFG among all the isolates (VEC: 80%, obstetric IEC:
76%), in contrast with earlier obstetric IEC isolates from the same hospital (only 18%) [22].
The direct links to iron-limited environments [27] and virulence as well as invasiveness have
previously been confirmed by studies in bacteraemic E. coli strains [6]. It has been demon-
strated that iron obtained through iron-uptake systems, such as heme, aerobactin, yersiniabac-
tin or siderophores is necessary in UTIs and these systems show specific functions depending
on the anatomical site [28] and may be targets for interventions, such as vaccines [29,30].
Higher percentages of genes associated with pathogenicity islands (PAIs), such as the hlyA,
cnf1 and pap- genes [31], have been observed among isolates from skin and soft tissue infec-
tions (SSTIs) [7], causing neonatal sepsis [32] as well as from patients with different sources of
bacteraemia [8]. The relatively low frequency of these genes in our study is similar to that of
VEC from East Japan, but lower than in strains fromWest Japan [1], United States [33], Slove-
nia [34] or Barcelona [17], suggesting the heterogeneity of E. coli strains to geographical area.
However, the prevalence of the toxin cnf1 was higher than that found in previous obstetric IEC
isolates from our hospital (25% vs. 9%) [22]. In contrast to other studies [1], [8], [32], [35], the
least prevalent VFGs were focG and ibeA, being found in less than 10% of obstetric infection
isolates. Unlike previous obstetric IEC isolates, isolates causing sepsis presented the same per-
centage of the invasin ibeA than VEC in this study [22].
Similar to the results of other studies, more than half of the isolates in the present study
belonged to virulence group B2 [11], [17]. The relevant statistically percentage of strains
belonging to group A considerably differed from that reported by Iranpour et al. [12].
Vaginal and Obstetric Infection E. coli Isolates
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Surprisingly, group E and non-typeable strains were frequently observed compared to the
results of Clermont et al. [13], which may be due to the great diversity, the extreme peculiarity
or a recombination between phylo-groups among E. coli strains.
Group B2 presented the highest number of VFs among all the strains, in agreement with
other studies performed in strains isolated from extraintestinal sites [5], [7], [36]. In contrast to
prior findings, ciprofloxacin-resistant strains did not belong to non-B2 phylogenetic groups
and neither did they show a loss of VFs related to PAIs [7], [37–39] However, the lower pres-
ence of these VFGs among tetracycline-resistant isolates causing obstetric infections was con-
cordant with the results of Soto et al. [39]. Furthermore, the selection of ampicillin-resistant
strains presenting high rates of VFs has been previously shown by Petkovsek et al. [7]. Regard-
less of the ecological and host-dependent factors with respect to the severity of infection [6],
[34], these strains have been shown to cause obstetric and neonatal infections and may have a
serious clinical impact [4], [40].
The present study has some limitations since data on characterization of vaginal and obstet-
ric infections E. coli strains are scarce, and many comparisons are made using other types of
extraintestinal isolates. However, besides the virulence profile of VEC resembling that of
ExPEC isolates, our findings are useful to generate relevant hypotheses on this little-known
topic because of the relationship of a wide range of VFs and antimicrobial agents with the new
phylogenetic analysis.
Table 3. Prevalence of virulence factor genes (VFGs) among the phylogenetic groups and the type of isolates according to their ampicillin
resistance.
Ampicillin Resistancee
Phylogenetic group VECb isolates Obstetric IECc isolates
VFGsa B2 Othersd AMP-S AMP-R AMP-S AMP-R
(n = 75) (n = 70) (n = 31) (n = 51) (n = 44) (n = 19)
hlyA 29 (39)** 2 (3) 1 (3) 18 (35)** 8 (18) 4 (21)
cnf1 31 (41)** 3 (4) 1 (3) 17 (33)** 11 (25) 5 (26)
sat1 27 (36) 29 (41) 11 (35.5) 18 (35) 16 (36) 11 (58)
papa 35 (47)** 16 (23) 7 (23) 16 (31) 16 (36) 12 (63)
papEF 24 (32) 14 (20) 3 (10) 18 (35)** 12 (27) 6 (32)
papC 30 (40)** 14 (20) 5 (16) 15 (29) 15 (34) 9 (47)
focG 12 (16)** 1 (1) 1 (3) 8 (16) 2 (4.5) 2 (10.5)
Hra 34 (45)** 17 (24) 5 (16) 24 (47)** 15 (34) 7 (37)
fyuA 71 (95)** 43 (61) 19 (61) 47 (92)** 33 (75) 15 (79)
iutA 34 (45) 43 (61) 12 (39) 25 (49) 28 (34) 12 (63)
iroN 33 (44)* 19 (27) 3 (10) 26 (51)** 17 (39) 6 (32)
iucC 34 (45) 46 (66)* 13 (42) 28 (55) 30 (68) 9 (47)
ibeA 14 (19)** 1 (1) 5 (16) 8 (16) 2 (4.5) 0
aVFGs: Virulence Factor Genes
bVEC isolates: Vaginal Escherichia coli isolates
cObstetric IEC isolates: Obstetric Infection Escherichia coli isolates
dOthers: A, E, Non-typeable, F, C, B1, D and E clade 1
eAmpicillin resistance: AMP, ampicillin; S, Susceptible; R, Resistant.
*p-value<0.05,
**p-value0.01
doi:10.1371/journal.pone.0146531.t003
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In conclusion, vaginal E. coli colonization may be a risk factor for complications during
pregnancy, especially if these strains are ampicillin-resistant and show many virulence factors
resulting in treatment failure or infections. Therefore, it is important to know the resistance
and virulence associated with E. coli strains from different anatomic sites [2] in order to deter-
mine the probability and the severity of infection these strains may cause. The characterization
of E. coli isolates which colonize the vagina and cause obstetric infections may be especially of
help to develop interventions, and avoid the causal link between maternal carriage and obstet-
ric and subsequent puerperal infections.
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